Amoxicillin/Clavulanate Pediatric Dosing
For most pediatric infections, use high-dose amoxicillin/clavulanate at 90 mg/kg/day of the amoxicillin component divided into 2 doses (maximum 4000 mg/day), which provides optimal coverage against resistant Streptococcus pneumoniae and β-lactamase-producing organisms. 1
Standard Dosing Regimens by Indication
Respiratory Tract Infections (Pneumonia, Sinusitis)
For children under 5 years with community-acquired pneumonia:
- 90 mg/kg/day of amoxicillin component in 2 divided doses 1, 2
- This high-dose regimen is specifically indicated for presumed bacterial pneumonia 3
For children 5 years and older with pneumonia:
For β-lactamase producing H. influenzae:
Acute Otitis Media
High-dose regimen (90 mg/kg/day with 6.4 mg/kg/day clavulanate in 2 divided doses) is indicated for: 3
- Children who received antibiotics within the past 4-6 weeks 1
- Age less than 2 years 3
- Daycare attendance 3
- Incomplete H. influenzae type b vaccination 3
- Moderate to severe illness 3
Age-Based Oral Suspension Dosing (Standard Formulations)
For children less than 1 year (1-12 months):
- 2.5 mL of 125/31 suspension three times daily 3
For children 1-6 years:
- 5 mL of 125/31 suspension three times daily 3
For children 7-12 years:
- 5 mL of 250/62 suspension three times daily 3
For children 12-18 years:
- 1 tablet (250/125) three times daily 3
Critical Dosing Principles
The high-dose formulation (90/6.4 mg/kg/day) provides a 14:1 ratio of amoxicillin to clavulanate, which causes less diarrhea than other preparations while maintaining efficacy. 3
Maximum single dose is 2 grams per dose regardless of weight. 3
For infants less than 3 months, the maximum recommended dose is 30 mg/kg/day divided every 12 hours due to incompletely developed renal function. 4
Treatment Duration and Monitoring
Standard treatment duration is 10 days for most respiratory infections, particularly pneumonia. 1, 3, 2
Children should demonstrate clinical improvement within 48-72 hours of starting therapy. 1, 2
If no improvement occurs within 48-72 hours, reevaluation and further investigation are necessary, including consideration of atypical pathogens or complications. 1, 2
Formulation Selection
The high-dose formulation (600 mg amoxicillin per 5 mL) is preferred for:
- Community-acquired pneumonia 1, 2
- Areas with high pneumococcal resistance (>10%) 3
- Recent antibiotic exposure 1
- Risk factors for resistant organisms 3
Standard formulations (125/31 or 250/62) may be used for:
Common Pitfalls to Avoid
Always verify the suspension concentration (125/31 vs 250/62 vs 600/42.9) before calculating volume to avoid dosing errors. 3
Using standard doses when high-dose therapy is indicated leads to treatment failure with resistant organisms. 3
Subtherapeutic doses fail to achieve adequate tissue concentrations and promote antimicrobial resistance. 3
Do not use the 875 mg tablet formulation in patients with severe renal impairment (GFR <30 mL/min). 4
Renal Impairment Dosing (for children >40 kg)
For GFR 10-30 mL/min:
- 500 mg or 250 mg every 12 hours, depending on infection severity 4
For GFR <10 mL/min:
- 500 mg or 250 mg every 24 hours, depending on infection severity 4
For hemodialysis patients:
- 500 mg or 250 mg every 24 hours, with an additional dose during and at the end of dialysis 4
Administration Instructions
Administer at the start of a meal to minimize gastrointestinal intolerance. 4
Shake oral suspension well before each use. 4
After reconstitution, discard any unused suspension after 14 days; refrigeration is preferable but not required. 4